Frequency: one subcutaneous injection each day , preferably in the evening to align with the bodys natural nocturnal growth-hormone release [2]
For those unable to have an IV, or who have completed our NAD IV protocol it can be given as a long term anti-aging treatment subcutaneously
This is characterized by increased expression of pro-inflammatory genes (IL-1, IL-6 and TNF-) and decreased expression of anti-viral and antibody genes (e.g., IFNs) [71]
Safety & Certifications Dermatologically tested Crueltyfree Free from parabens, sulfates & mineral oil Noncomedogenic Patch test recommended for sensitive skin Social Proof & Results Visible brightening effect Reduced pigmentation and dark spots Hydrated, smooth complexion Radiant glow with consistent use 0 out of 5 5 out of 5 4 out of 5 3 out of 5 2 out of 5 1 out of 5 Reviews Clear filters There are no reviews yet.
Currently, there are four main treatments propelling this market forward: Ozempic and Wegovy (semaglutide: a GLP-1 agonist, developed by Novo Nordisk) Mounjaro and Zepbound (tirzepatide: a dual agonist targeting both GLP-1 and GIP (Gastric inhibitory polypeptide) receptors, developed by Eli Lilly) These medications are administered subcutaneously with the assistance of injection pens
